SEC Form 4 · accession 0001209191-17-039224
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Sherwin
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 12, 2017 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.55 | Jun 8, 2017 | A | 13,000 | A | — | Jun 7, 2027 | Common Stock | 13,000 | 13,000 | D |
Explanation of responses
- F1The shares subject to the Option will vest quarterly over one year from the grant date of June 8, 2017, such that the shares will be fully vested on the first anniversary of the date of grant.